Integrative analysis reveals disrupted pathways regulated by microRNAs in cancer

TL;DR

This study introduces a novel integrative approach combining pathway information and expression data to identify miRNA-pathway disruptions in cancer, revealing systems-level regulatory changes associated with tumorigenesis.

Contribution

The paper presents a new method that uses pathway-aware analysis of miRNA and mRNA expression data to detect disrupted regulatory relationships in cancer.

Findings

Identified specific miRNA-pathway associations disrupted in tumors

Revealed systemic regulatory changes in four cancer types

Many flagged pairs have biological relevance to cancer mechanisms

Abstract

MicroRNAs (miRNAs) are small endogenous regulatory molecules that modulate gene expression post-transcriptionally. Although differential expression of miRNAs have been implicated in many diseases (including cancers), the underlying mechanisms of action remain unclear. Because each miRNA can target multiple genes, miRNAs may potentially have functional implications for the overall behavior of entire pathways. Here we investigate the functional consequences of miRNA dysregulation through an integrative analysis of miRNA and mRNA expression data using a novel approach that incorporates pathway information a priori. By searching for miRNA-pathway associations that differ between healthy and tumor tissue, we identify specific relationships at the systems-level which are disrupted in cancer. Our approach is motivated by the hypothesis that if a miRNA and pathway are associated, then the expression of the miRNA and the collective behavior of the genes in a pathway will be correlated. As such, we first obtain an expression-based summary of pathway activity using Isomap, a dimension reduction method which can articulate nonlinear structure in high-dimensional data. We then search for miRNAs that exhibit differential correlations with the pathway summary between phenotypes as a means of finding aberrant miRNA-pathway coregulation in tumors. We apply our method to cancer data using gene and miRNA expression datasets from The Cancer Genome Atlas (TCGA) and compare ${\sim}10^5$ miRNA-pathway relationships between healthy and tumor samples from four tissues (breast, prostate, lung, and liver). Many of the flagged pairs we identify have a biological basis for disruption in cancer.